|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jaganathan SK, Vellayappan MV, Narasimhan
G and Supriyanto E: Role of pomegranate and citrus fruit juices in
colon cancer prevention. World J Gastroenterol. 20:4618–4625. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen J, Elfiky A, Han M, Chen C and Saif
MW: The role of Src in colon cancer and its therapeutic
implications. Clin Colorectal Cancer. 13:5–13. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kawaji H, Nakamura M, Takahashi Y,
Sandelin A, Katayama S, Fukuda S, Daub CO, Kai C, Kawai J, Yasuda
J, et al: Hidden layers of human small RNAs. BMC Genomics.
9:1572008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cole C, Sobala A, Lu C, Thatcher SR,
Bowman A, Brown JW, Green PJ, Barton GJ and Hutvagner G: Filtering
of deep sequencing data reveals the existence of abundant
Dicer-dependent small RNAs derived from tRNAs. RNA. 15:2147–2160.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee YS, Shibata Y, Malhotra A and Dutta A:
A novel class of small RNAs: TRNA-derived RNA fragments (tRFs).
Genes Dev. 23:2639–2649. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Thompson DM and Parker R: Stressing out
over tRNA cleavage. Cell. 138:215–219. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Martens-Uzunova ES, Olvedy M and Jenster
G: Beyond microRNA - novel RNAs derived from small non-coding RNA
and their implication in cancer. Cancer Lett. 340:201–211. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kumar P, Anaya J, Mudunuri SB and Dutta A:
Meta-analysis of tRNA derived RNA fragments reveals that they are
evolutionarily conserved and associate with AGO proteins to
recognize specific RNA targets. BMC Biol. 12:782014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Muller S, Raulefs S, Bruns P, Afonso-Grunz
F, Plötner A, Thermann R, Jäger C, Schlitter AM, Kong B, Regel I,
et al: Next-generation sequencing reveals novel differentially
regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic
cancer. Mol Cancer. 14:942015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Olvedy M, Scaravilli M, Hoogstrate Y,
Visakorpi T, Jenster G and Martens-Uzunova ES: A comprehensive
repertoire of tRNA-derived fragments in prostate cancer.
Oncotarget. 7:24766–24777. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Balatti V, Nigita G, Veneziano D, Drusco
A, Stein GS, Messier TL, Farina NH, Lian JB, Tomasello L, Liu CG,
et al: tsRNA signatures in cancer. Proc Natl Acad Sci U S A.
114:8071–8076. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Maute RL, Schneider C, Sumazin P, Holmes
A, Califano A, Basso K and Dalla-Favera R: tRNA-derived microRNA
modulates proliferation and the DNA damage response and is
down-regulated in B cell lymphoma. Proc Natl Acad Sci U S A.
110:1404–1409. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kozomara A and Griffiths-Jones S: miRBase:
Annotating high confidence microRNAs using deep sequencing data.
Nucleic Acids Res. 42:D68–D73. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Balatti V, Rizzotto L, Miller C,
Palamarchuk A, Fadda P, Pandolfo R, Rassenti LZ, Hertlein E,
Ruppert AS, Lozanski A, et al: TCL1 targeting
miR-3676 is codeleted with tumor protein p53 in chronic
lymphocytic leukemia. Proc Natl Acad Sci USA. 112:2169–2174. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qi L and Ding Y: Screening of
differentiation-specific molecular biomarkers for colon cancer.
Cell Physiol Biochem. 46:2543–2550. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang L, Wang S, Zhou Y, Lai S, Xiao G,
Gazdar A and Xie Y: Evaluation of the 7th and 8th editions of the
AJCC/UICC TNM staging systems for lung cancer in a large North
American cohort. Oncotarget. 8:66784–66795. 2017.PubMed/NCBI
|
|
19
|
Nawrocki EP, Burge SW, Bateman A, Daub J,
Eberhardt RY, Eddy SR, Floden EW, Gardner PP, Jones TA, Tate J, et
al: Rfam 12.0: Updates to the RNA families database. Nucleic Acids
Res. 43:D130–D137. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kalvari I, Argasinska J, Quinones-Olvera
N, Nawrocki EP, Rivas E, Eddy SR, Bateman A, Finn RD and Petrov AI:
Rfam 13.0: Shifting to a genome-centric resource for non-coding RNA
families. Nucleic Acids Res. 46:D335–D342. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tang Z, Li C, Kang B, Gao G and Zhang Z:
GEPIA: A web server for cancer and normal gene expression profiling
and interactive analyses. Nucleic Acids Res. 45:W98–W102. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hulsegge I, Kommadath A and Smits MA:
Globaltest and GOEAST: Two different approaches for gene ontology
analysis. BMC Proc. 4 (Suppl 3):S102009. View Article : Google Scholar
|
|
25
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The Gene
Ontology Consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kuscu C, Kumar P, Kiran M, Su Z, Malik A
and Dutta A: tRNA fragments (tRFs) guide Ago to regulate gene
expression post-transcriptionally in a Dicer independent manner.
RNA. 24:1093–1105. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu X, Duan B, Dong Y, He C, Zhou H, Sheng
H, Gao H and Zhang X: MicroRNA-139-3p indicates a poor prognosis of
colon cancer. Int J Clin Exp Pathol. 7:8046–8052. 2014.PubMed/NCBI
|
|
29
|
Ng L, Wan TM, Man JH, Chow AK, Iyer D,
Chen G, Yau TC, Lo OS, Foo DC, Poon JT, et al: Identification of
serum miR-139-3p as a non-invasive biomarker for colorectal cancer.
Oncotarget. 8:27393–27400. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li H, Dai S, Zhen T, Shi H, Zhang F, Yang
Y, Kang L, Liang Y and Han A: Clinical and biological significance
of miR-378a-3p and miR-378a-5p in colorectal cancer. Eur J Cancer.
50:1207–1221. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Torres S, Garcia-Palmero I, Bartolome RA,
Fernandez-Aceñero MJ, Molina E, Calviño E, Segura MF and Casal JI:
Combined miRNA profiling and proteomics demonstrates that different
miRNAs target a common set of proteins to promote colorectal cancer
metastasis. J Pathol. 242:39–51. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yong FL, Law CW and Wang CW: Potentiality
of a triple microRNA classifier: MiR-193a-3p, miR-23a and
miR-338-5p for early detection of colorectal cancer. BMC cancer.
13:2802013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cui H, Liu Y, Jiang J, Liu Y, Yang Z, Wu
S, Cao W, Cui IH and Yu C: IGF2-derived miR-483 mediated
oncofunction by suppressing DLC-1 and associated with colorectal
cancer. Oncotarget. 7:48456–48466. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Schee K, Lorenz S, Worren MM, Günther CC,
Holden M, Hovig E, Fodstad O, Meza-Zepeda LA and Flatmark K: Deep
sequencing the MicroRNA transcriptome in colorectal Cancer. PloS
One. 8:e661652013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Komatsu S, Yanaka N, Matsubara K and Kato
N: Antitumor effect of vitamin B6 and its mechanisms. Biochim
Biophys Acta. 1647:127–130. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Meeker S, Seamons A, Paik J, Treuting PM,
Brabb T, Grady WM and Maggio-Price L: Increased dietary vitamin D
suppresses MAPK signaling, colitis, and colon cancer. Cancer Res.
74:4398–4408. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pereira F, Larriba MJ and Munoz A: Vitamin
D and colon cancer. Endocr Relat Cancer. 19:R51–R71. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Schernhammer ES, Ogino S and Fuchs CS:
Folate and vitamin B6 intake and risk of colon cancer in
relation to p53 expression. Gastroenterology. 135:770–780. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Toya K, Hirata A, Ohata T, Sanada Y, Kato
N and Yanaka N: Regulation of colon gene expression by vitamin B6
supplementation. Mol Nutr Food Res. 56:641–652. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Komatsu SI, Watanabe H, Oka T, Tsuge H,
Nii H and Kato N: Vitamin B-6-supplemented diets compared with a
low vitamin B-6 diet suppress azoxymethane-induced colon
tumorigenesis in mice by reducing cell proliferation. J Nutr.
131:2204–2207. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang P, Suidasari S, Hasegawa T, Yanaka N
and Kato N: Vitamin B6 activates p53 and elevates p21
gene expression in cancer cells and the mouse colon. Oncol Rep.
31:2371–2376. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Orlando A, Linsalata M, Tutino V, D'Attoma
B, Notarnicola M and Russo F: Vitamin K1 exerts antiproliferative
effects and induces apoptosis in three differently graded human
colon cancer cell lines. Biomed Res Int. 2015:2967212015.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li N, Xi Y, Tinsley HN, Gurpinar E, Gary
BD, Zhu B, Li Y, Chen X, Keeton AB, Abadi AH, et al: Sulindac
selectively inhibits colon tumor cell growth by activating the
cGMP/PKG pathway to suppress Wnt/β-catenin signaling.
Mol Cancer Ther. 12:1848–1859. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li N, Chen X, Zhu B, Ramírez-Alcántara V,
Canzoneri JC, Lee K, Sigler S, Gary B, Li Y, Zhang W, et al:
Suppression of β-catenin/TCF transcriptional activity
and colon tumor cell growth by dual inhibition of PDE5 and 10.
Oncotarget. 6:27403–27415. 2015.PubMed/NCBI
|
